Stay updated on Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the history, and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-22T20:47:53.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The history shows a new site revision label v3.3.2 added, with the previous v3.3.1 label removed.
    Difference
    0.1%
    Check dated 2025-12-01T16:15:08.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 appears in the history, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:09:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Removed the notice about lapse in government funding and operating status from the page. The study record history content remains unchanged.
    Difference
    0.7%
    Check dated 2025-11-17T06:09:49.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The Record History shows multiple version updates (Study Status, Recruitment Status, and Outcome Measures) across 2020-2024, reflecting administrative changes to the trial record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:46:12.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    12%
    Check dated 2025-10-05T08:14:38.000Z thumbnail image

Stay in the know with updates to Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.